LIF vs QLYS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
LIF presents a contradictory profile: strong growth and profitability metrics are offset by a weak Piotroski F-Score of 3/9, indicating deteriorating fundamental health. While the current price of $38.10 is well below the growth-based intrinsic value of $52.22, it trades at a significant premium to the Graham Number ($9.58). The stock is currently in a severe technical downtrend, losing over 63% of its value in the last six months, compounded by bearish insider selling. Despite these red flags, the low P/E relative to the tech sector and strong revenue growth maintain a neutral outlook rather than a fully bearish one.
Qualys exhibits a dichotomy between strong fundamental health and severe market pessimism. The Piotroski F-Score of 4/9 indicates a stable financial condition, supported by an exceptionally low Debt/Equity ratio (0.09) and high gross margins (82.85%). While the stock is trading significantly below its growth-based intrinsic value ($160.48) and carries an attractive forward P/E of 10.42, this is offset by a bearish technical trend (0/100) and consistent insider selling. The company is a high-quality operator currently trapped in a valuation reset.
Compare Another Pair
Related Comparisons
LIF vs QLYS: Head-to-Head Comparison
This page compares Life360, Inc. (LIF) and Qualys, Inc. (QLYS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.